Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis
The Journal of Clinical Endocrinology & Metabolism · 16.06.2023 · 108 (7) · 1813-1823
DOI: 10.1210/clinem/dgad044 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 31.01.2023. Verfasst von Elisa Sconfienza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Via Genova 3, 10126 Torino, Italy. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Cushing Syndrome, Hypertension, Pheochromocytoma. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Context
Adrenal hyperfunction is associated with an increased risk of cardiometabolic complications in subjects with adrenal incidentaloma (AI). Reliable prevalence estimates of functioning AIs are important to direct resources allocations.
Objective
To assess the prevalence of autonomous/possible autonomous cortisol secretion (ACS), primary aldosteronism (PA), pheochromocytoma (PHEO), and Cushing syndrome (CS) in patients with AI.
Methods
We performed a comprehensive search of multiple databases (PubMed, Ovid MEDLINE, Web of Science) for potentially relevant studies without language restriction, up to February 2022. Of the 1661 publications evaluated at title and abstract levels, 161 were examined as full text and 36 were included. Study level clinical data were extracted by 3 independent reviewers.
Results
The overall prevalence of functioning AIs was 27.5% (95% CI 23.0, 32.5). ACS/possible ACS, with a prevalence of 11.7% (95% CI 8.6, 15.7), was the most frequent hormonal alteration, while PA occurred in 4.4% of the patients (95% CI 3.1, 6.2). Subgroup analysis showed that PA was more prevalent in patients from Asia than in patients from Europe/America; in contrast, ACS/possible ACS had a lower prevalence in Asian countries. At meta-regression analysis, the prevalence of ACS/possible ACS was influenced by the proportion of female patients, while the prevalence of PA was positively associated with the proportion of patients with hypertension and the publication year. Finally, PHEO and CS prevalence were 3.8% (95% CI 2.8, 5.0) and 3.1% (95% CI 2.3, 4.3) respectively.
Conclusion
This meta-analysis provides extensive data on the prevalence of functioning AIs and the factors affecting heterogeneity in prevalence estimates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Via Genova 3, 10126 Torino, Italy.
ORCID-Profile: Franco Veglio, Paolo Mulatero, Silvia Monticone
Zitieren
APA
Sconfienza, E., Tetti, M., Forestiero, V., Veglio, F., Mulatero, P., & Monticone, S. (2023). Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 108(7), 1813-1823. https://doi.org/10.1210/clinem/dgad044
Vancouver
Sconfienza E, Tetti M, Forestiero V, Veglio F, Mulatero P, Monticone S. Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2023;108(7):1813-1823. doi:10.1210/clinem/dgad044
BibTeX
@article{Sconfienza2023,
author = {Sconfienza, Elisa and Tetti, Martina and Forestiero, Vittorio and Veglio, Franco and Mulatero, Paolo and Monticone, Silvia},
title = {Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {7},
pages = {1813--1823},
doi = {10.1210/clinem/dgad044}
}
EUVIMED